Azenta, Inc. (AZTA)
Stores and analyzes biological samples for life sciences research and testing.
$28.63+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-11.5%
The outlook
Azenta trades near the middle of its 52-week range, sitting above both its 50- and 200-day moving averages. Analyst consensus leans bullish with a "Buy" rating, though the average price target sits about 3% below the current price. The stock's overall lean is moderately positive based on current market positioning.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range49% of the way from its 52-week low to high
Price targetAvg target -3% vs current price
Analyst price target
~12-month · 5 analysts$27.80average target-2.9% vs now
Now $28.63
Low $20.00High $33.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.32B
52-wk high
$41.73
52-wk low
$15.93
50-day avg
$23.51
200-day avg
$28.09
Trailing P/E
—